Search the Newsreel

Dimensional Fund Advisors LP Sells 121,412 Shares of Sarepta Therapeutics, Inc. $SRPT

Dimensional Fund Advisors LP significantly reduced its stake in Sarepta Therapeutics, Inc. by selling 121,412 shares, leaving them with 336,736 shares valued at $7.3 million. Despite institutional investors owning a large portion of the company and some increasing their positions, analyst sentiment is mixed, …

Sarepta Therapeutics, Inc. (SRPT) Investor Outlook: Analyzing The 31.63% Potential Upside

Sarepta Therapeutics (SRPT) is a biotechnology firm focusing on RNA-targeted therapeutics and gene therapies for rare diseases like Duchenne muscular dystrophy, with a market capitalization of $1.77 billion. Despite a revenue decline of 34.30% and negative EPS, analysts project a 31.63% potential upside, driven …

Synaptics Incorporated (SYNA) Options Chain

This article provides detailed options chain data for Synaptics Incorporated (SYNA) for March 19, 2027, including both calls and puts. It lists strike prices, last trade dates, last prices, bid/ask, change, volume, open interest, and implied volatility for various contracts. The article also includes …

Credit Acceptance’s Q2 Earnings Call: Our Top 5 Analyst Questions

Credit Acceptance's Q2 Earnings Call: Our Top 5 Analyst Questions Credit Acceptance's second quarter results reflected a mix of margin expansion and modest loan volume improvements, even as revenue growth remained limited. Management highlighted that profitability gains stemmed from deliberate operational changes, including tighter …

Aptitude Software Group (APTD) Names Kenneth Paqvalén as CFO Effective September 21, 2026

Crypto-blockchain Industries, Sa : Activité de Minage de Bitcoins pour le Mois de Juillet 2026

Easterly Government Properties to Participate in NYSE Real Estate Investor Access Day

Easterly Government Properties, Inc. (NYSE: DEA) announced its management will participate in virtual investor meetings at the NYSE Real Estate Investor Access Day on August 11, 2026. The company, a REIT specializing in properties leased to the U.S. Government, has made presentation materials available …

Thrivent Financial (AIRS) discloses 4.4M-share beneficial stake in Airsculpt

Thrivent Financial and its affiliate Thrivent Investment Capital Advisors, LLC (TICA) have disclosed a beneficial ownership of 4,425,000 shares, or 6.3% of the class, in Airsculpt Technologies, Inc. This stake is held through Thrivent White Rose Fund XI Equity Direct, L.P. The filing, an …

Millennium & Copthorne Hotels New Zealand H1 Earnings, Revenue Up; Shares Jump 3%

Hong Kong Market Midday Commentary | All three major indices declined, with the Hang Seng Tech Index down 1.27%; tech and internet stocks fell, with Kuaishou and JD.com each dropping nearly 3%; biotech stocks rose, as GenScript Biotech surged over 8

Harga Saham Garuda Indonesia Terbang Menyusul Isu Konsolidasi dengan Pelita Air

Septerna (NASDAQ:SEPN) Hits New 1-Year High - Still a Buy?

Septerna (NASDAQ:SEPN) recently hit a new 52-week high of $40.65, trading around $38.26, significantly above its moving averages. The clinical-stage biotech reported better-than-expected quarterly earnings, with a loss of $0.19 per share against an anticipated $0.42 loss, and revenues of $26.52 million, exceeding estimates …

Telekomunikasi Indonesia (NYSE: TLK) director files Form 3 with no holdings

Why PROCEPT BioRobotics (PRCT) Is Up 9.6% After Reaffirming 2026 Revenue Guidance Despite Wider Losses

PROCEPT BioRobotics (PRCT) saw its stock rise 9.6% despite reporting wider net losses in Q2 2026, driven by reaffirming its full-year 2026 revenue guidance of US$390 million to US$410 million. The company's investment narrative centers on Aquablation adoption and the path to sustainable profitability, …

Why Did Millennium & Copthorne Hotels New Zealand (NZX:MCK) Lift Profit in 2026? Key Growth Drivers Explained

Adapthealth director Dale Wolf buys $244,600 in company stock

Dale B. Wolf, a director at AdaptHealth Corp. (NASDAQ:AHCO), recently purchased 40,000 shares of company stock for $244,600 in early August 2026, with prices between $5.83 and $6.37 per share. These insider purchases occurred while AHCO shares traded near their 52-week low, and InvestingPro …

AdaptHealth (NASDAQ:AHCO) Director Purchases $149,930.00 in Stock

AdaptHealth (NASDAQ:AHCO) Director Kenneth Samet recently purchased 23,500 shares for $149,930, increasing his stake by 93.74%. Despite the purchase and analysts' "Moderate Buy" rating with a $10.29 price target, the stock fell 8.3% to $5.22, nearing its one-year low, with trading volume more than …

PTC Inc. (PTC) Stock Forecasts

This article provides a stock forecast for PTC Inc. (PTC), highlighting its position as a global technology company offering CAD, PLM, and AR solutions to industrial manufacturers. A Morningstar analyst report, dated August 10, 2026, details PTC's earnings, emphasizing how resources from divestitures support …

Is PTC Therapeutics (PTCT) Undervalued As Profit And Revenue Guidance Jumped?

PTC Therapeutics reported a significant shift from a loss to a net income of US$83.5 million in Q2 2026 and raised its full-year revenue guidance to US$1.18b-US$1.28b. Despite a recent share price increase of 9.56% over the past week, the stock is considered 23% …

Septerna, Inc. (SEPN) Reports Q2 Loss, Beats Revenue Estimates

Septerna, Inc. (SEPN) reported a Q2 loss of $0.29 per share, beating the Zacks Consensus Estimate of a $0.48 loss and surpassing last year's $0.56 loss. The company's revenues for the quarter reached $26.75 million, significantly exceeding the Zacks Consensus Estimate by 30.07%. Despite …

Kinerja Widodo Makmur (WMPP) Membaik, Laba Tembus Rp123,5 Miliar - Bisnis.com

SYNAPTICS Inc FY 2026: Revenue $1.2B, EPS ($12.62) — 10-K Summary

SYNAPTICS Inc reported a full-year 2026 net revenue of $1.2 billion, an 11.4% increase from the previous year, according to its 10-K filing. However, the company recorded a net loss of $490.8 million and a diluted EPS of ($12.62), largely due to a significant …

Earnings Flash (SEPN) Septerna, Inc. Reports Q2 Revenue $26.7M, vs. FactSet Est of $19.2M

Septerna, Inc. (SEPN) reported its second-quarter revenue of $26.7 million, significantly surpassing FactSet's estimate of $19.2 million. This financial news also notes that the company's Q2 loss per share narrowed to $0.29, compared to an estimated loss of $0.43. Septerna is a clinical-stage biotechnology …

Septerna (NASDAQ:SEPN) Releases Earnings Results, Beats Expectations By $0.14 EPS

Septerna (NASDAQ:SEPN) announced its latest earnings results, reporting an adjusted loss of $0.29 per share, which beat analyst expectations by $0.14. The company's revenue also surpassed estimates, reaching $26.75 million against a consensus of $19.22 million. Despite strong financial performance and a "Moderate Buy" …

Septerna Q2 Results: Sales surge 22,380% YoY to $26.746M

Septerna reported a significant revenue surge to $26.7 million in Q2 2026, primarily due to its collaboration with Novo Nordisk, a dramatic increase from $0.1 million in Q2 2025. The company also narrowed its net loss to $13.0 million and maintains a strong cash …

Syntec Optics Raises About $21.4M Net in Public Equity Offering

ADPT (ADPT) insider outlines Form 144 sale of 3,000 shares

A holder of Adaptive Biotechnologies Corp (ADPT) common stock has filed a Form 144, indicating an intention to sell 3,000 shares valued at $74,790.00 through Morgan Stanley Smith Barney. These shares are Restricted Stock Units acquired from the issuer on March 4, 2023. The …

Septerna (SEPN) boosts collaboration revenue and extends cash runway into 2029

Syntec Optics Announces Q2 2026 Earnings: Revenue Growth, $21.4M Stock Raise, and Stronger Balance Sheet

Syntec Optics Holdings, Inc. reported strong Q2 2026 earnings, reversing a net loss from the previous year with a net income of $256,237 and a significant increase in net sales to $8.27 million. The company also raised $21.4 million through a common stock issuance, …

Barclays Maintains Aptiv PLC(APTV.US) With Buy Rating, Cuts Target Price to $65

Barclays has reiterated its Buy rating for Aptiv PLC (APTV.US) but has lowered its price target to $65 from $82. This adjustment reflects an updated outlook from the analyst firm while still maintaining a positive stance on the company's stock.

Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $5.00 at Truist Financial

Truist Financial has increased its price target for Treace Medical Concepts (NASDAQ:TMCI) from $4.00 to $5.00, while maintaining a "hold" rating, suggesting a potential upside of 10.13%. Despite this, the broader analyst consensus remains "Reduce" with a target of $5.17. The company recently reported …

SYNA Q4 Earnings Beat Estimates, Strong Core IoT Sales Aid Revenues

Synaptics (SYNA) reported strong fourth-quarter fiscal 2026 results, with non-GAAP earnings and revenues surpassing estimates, largely driven by a 24% year-over-year increase in Core IoT product sales. The company achieved its highest operating margin in 13 quarters at 20% and generated significant cash flow, …

AirSculpt anticipates $12M-$14M adjusted EBITDA while rolling out AlloClae partnership

Earnings Call Insights: AirSculpt Technologies, Inc. (AIRS) Q2 2026 MANAGEMENT VIEW * “For the quarter, on a comparable basis, we delivered stable revenue and positive same-center case growth,” said (CEO & Director Yogesh Jashnani), adding that “Center sales began the quarter positively and saw …

Optimum Q2 Earnings Miss Tests Its 2026 Outlook and Cost Discipline

Is OPTU Stock a Buy as Mobile Growth Meets Debt and Revenue Risks?

Optimum Communications, Inc. OPTU is expanding its mobile business, improving operating efficiency and investing in network modernization. However, declining residential revenue, elevated leverage and negative free cash flow complicate the investment case. The stock's Zacks Rank and Style Scores point to a setup that …

OPTU Stock Falls 28% in a Month: Is the Weakness an Opportunity?

Shares of Optimum Communications, Inc. OPTU have declined 28% in the past month, putting the spotlight on whether the sharp pullback reflects deteriorating fundamentals or creates an opportunity if the company's operational initiatives gain traction. Compared with larger telecom peers such as AT&T Inc. …